Elevated alanine aminotransferase Length of · participants with unresectable hepatocellular carcinoma
It is very uncertain whether external beam radiotherapy (EBRT) plus transarterial… changes elevated alanine aminotransferase Length of compared with TACE alone (very low certainty).
1 finding from 1 review
Elevated total bilirubin Length of · participants with unresectable hepatocellular carcinoma
It is very uncertain whether external beam radiotherapy (EBRT) plus transarterial… changes elevated total bilirubin Length of compared with TACE alone (very low certainty).
1 finding from 1 review
Eradication rate of gastric H. pylori · patients with gastric Helicobacter pylori infection
Eradication therapy combined with periodontal therapy probably leads to higher eradication rate of gastric H. pylori compared with eradication therapy alone (moderate certainty).
1 finding from 1 review
Non‐recurrence rate of gastric H. pylori · patients with gastric Helicobacter pylori infection
Eradication therapy combined with periodontal therapy may leads to higher non‐recurrence rate of gastric H. pylori compared with eradication therapy alone (low certainty).
1 finding from 1 review
Antibiotics prescribed by clinicians · patients (or parents of child patients) with acute upper respiratory tract infections
Written information for patients (or parents of child patients) plus… may leads to higher antibiotics prescribed by clinicians compared with prescribing feedback alone (low certainty).
1 finding from 1 review
Mean days to wellness Patient reports · patients with acute upper respiratory tract infections
1 finding from 1 review
Antibiotic usage Patient‐reported usage · patients with acute upper respiratory tract infections
It is very uncertain whether normal saline plus standard treatment changes antibiotic usage Patient‐reported usage compared with standard treatment alone (very low certainty).
1 finding from 1 review
Sore throat · patients with acute upper respiratory tract infections
1 finding from 1 review
All‐cause mortality · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV showed no clear difference in mortality compared with HAART alone (moderate certainty).
1 finding from 1 review
Kaposi's sarcoma IRIS · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + liposomal anthracycline showed no clear difference in kaposi's sarcoma IRIS compared with HAART alone (moderate certainty).
1 finding from 1 review
Progressive disease · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV probably leads to lower progressive disease compared with HAART alone (moderate certainty).
1 finding from 1 review
Clinical response ‐ complete response · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV showed no clear difference in clinical response ‐ complete response compared with HAART alone (moderate certainty).
1 finding from 1 review
Primary outcome: partial clinical response · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV probably leads to higher clinical response ‐ partial response compared with HAART alone (moderate certainty).
1 finding from 1 review
Clinical response ‐ stable disease · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV probably leads to lower clinical response ‐ stable disease compared with HAART alone (moderate certainty).
1 finding from 1 review
Complete or partial remission · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV probably leads to higher clinical response ‐ overall response (complete and partial) compared with HAART alone (moderate certainty).
1 finding from 1 review
Adverse events · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + ABV showed no clear difference in adverse events compared with HAART alone (moderate certainty).
1 finding from 1 review
Clinical response · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + pegylated liposomal doxorubicin showed no clear difference in clinical response compared with HAART alone (moderate certainty).
1 finding from 1 review
All‐cause mortality · HIV‐infected adults with severe (T1) Kaposi's sarcoma
HAART + liposomal anthracycline showed no clear difference in mortality compared with HAART alone (moderate certainty).
1 finding from 1 review
Complete response · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete Response to Tx compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 6.54 [1, 42.86]
36 participants
Very low
Complete response plus partial response Length of · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete/Partial Response to Tx compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 1.47 [0.87, 2.49]
36 participants
Very low